Guillaume et al. reported that SCNN1B is hypermethylated in renal cell carcinoma and is considered a new epigenetic marker for clear cell kidney carcinoma, which suggests it is a viable diagnostic test of urine or blood samples. This evidence concerns the gene SCNN1B and hereditary clear cell renal cell carcinoma.